Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

N.N. Petrov National Medical Research Center of Oncology · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
colorectalcancerlungcancermelanoma
ras mutation, ras (kras or nras) gene mutation, colorectal cancer recurrent, pancreas cancer, lung cancer, melanoma, refractory cancer, colorectal cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 883518
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.